Synonyms:Ixazomib, 1072833-77-2, MLN2238, MLN-2238, MLN 2238, (R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid, Ixazomib [INN], (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid, Ixazomib(MLN2238), Ixazomib (MLN2238), MLN-9708 FREE BASE, CHEMBL2141296, Ixazomib (USAN), [(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid, IXAZOMIB [USAN], [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid, Boronic acid, b-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-, 71050168A2, Ixazomib [USAN:INN], Ixozamib, Ixazomib Impurity, UNII-71050168A2, MLN2238(Ixazomib), IXAZOMIB [MI], IXAZOMIB [WHO-DD], Ixazomib (MLN-2238), GTPL8450, SCHEMBL3742758, CHEBI:90942, EX-A547, DTXSID701025662, AMY19380, BCP02410, BCP24078, BDBM50398609, MFCD18251438, NSC766907, s2180, AKOS015995120, BCP9000953, CCG-264938, CS-1657, DB09570, NSC-766907, 1072833-77-2 (free), NCGC00249611-01, NCGC00249611-03, NCGC00249611-04, AC-28456, AS-55976, HY-10453, SW219743-1, J3.602.191H, A25328, D10130, EN300-7360341, J-001749, BRD-K78659596-001-01-3, Q20948663, N-[(1R)-1-borono-3-methylbutyl]-N(2)-(2,5-dichlorobenzoyl)glycinamide, ((1R)-1-((2,5-DICHLOROBENZAMIDO)ACETAMIDO)-3-METHYLBUTYL)BORONIC ACID, (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid;Ixazomib, [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]boronic acid
Id:25183872
Description:nan